FLT190 - Phase 1/2 Clinical Trial
FLT190 - Phase 1/2 Clinical Trial
About This Event
Phase 1/2 dosing of additional patients due in 1Q 2022 and 1H 2022. Initial Phase 1/2 data to be presented at the Annual WORLDSymposium February 11, 2022. Escalation data due in 2H 2022. Additional data due in 1H 2023.
Why This Event Matters
Regulatory milestones can be important for biotech and pharmaceutical names because decisions may affect timelines, labeling, and commercial prospects. Outcomes are uncertain until confirmed by the company or agency materials; this listing is informational. The date shown is February 11, 2022 (America/New_York).
Source summary: Phase 1/2 dosing of additional patients due in 1Q 2022 and 1H 2022. Initial Phase 1/2 data to be presented at the Annual WORLDSymposium February 11, 2022. Escalation data due in 2H 2022. Additional data due in 1H 2023.
This listing is associated with FRLN. Market participants may watch these names around the event window for volatility or news flow.
Frequently Asked Questions
- What is FLT190 - Phase 1/2 Clinical Trial?
- It is a stock market catalyst entry on Catacal—an event or release investors and traders may monitor. Details are summarized from the cited source and may be updated over time.
- When is FLT190 - Phase 1/2 Clinical Trial?
- The calendar shows Feb 11, 2022 (America/New_York). Verify the exact time and any changes using the source link when planning around the event.
- Why does FLT190 - Phase 1/2 Clinical Trial matter for investors?
- Regulatory outcomes can change timelines and risk profiles for drug and device developers.
- Which stocks or sectors could be affected?
- Symbols linked to this listing include FRLN; other names in the same industry group may also move with related news.
- How is this event categorized?
- Catacal groups this entry under "FDA Approval" for navigation. Categories help you find comparable catalysts and build a week-by-week watchlist.
Track Market-Moving Events
Monitor earnings, economic releases, lockups, conferences, and other catalysts that impact stocks.
View Catalyst CalendarComprehensive Calendar
Track earnings, product launches, FDA approvals, economic events, and more.
Impact Ratings
Know which catalysts have the greatest potential to impact stock prices.
Never Miss an Event
Get alerts and reminders so you're always prepared for market-moving events.
View Catalyst Calendar
Track upcoming market events